Monitor for actual execution of the option exercise and sale in upcoming days; while this is a routine transaction, the full exercise of both options may indicate reduced confidence in near-term upside or simply tax/estate planning. Given Rubin’s prior monthly sales of ~7,433 shares, this appears consistent with an ongoing strategy rather than a one-time exit signal.
Price Chart
Executive Summary
Paul Rubin, an officer of BioAge Labs, filed a Form 144 notifying intent to sell up to 8,820 shares of common stock, exercisable via two stock options granted in 2020 and 2022, with the sale date reported as April 1, 2026. The filing reflects a planned exercise and sale of vested options, not an immediate large-scale disposition of existing holdings. Given the officer status and full exercise of available options, this signals moderate insider activity but is not unusually large in magnitude relative to market cap.
Key Facts
- Reporting owner: Paul Rubin, Officer of BioAge Labs, Inc.
- Number of shares intended for sale: 8,820 shares of common stock
- Shares to be acquired via exercise of two stock options: 5,437 shares (granted 07/01/2020) and 3,383 shares (granted 05/29/2022)
- Exercise method: Cash exercise
- Filing date: April 1, 2026
- Broker: Fidelity Brokerage Services LLC
- Market cap of BIOA: $776M
Financial Impact
Approximately 8,820 shares; based on prior monthly transactions (7,433 shares each month from Jan–Mar 2026) at average prices between $12.80–$20.00, estimated value of this proposed sale is ~$113,000–$176,000
Risk Factors
- Perception of insider selling could weigh on sentiment if market interprets this as lack of confidence
- Execution of the sale may result in minor near-term price pressure if completed in a short window
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-002686 |
| Document: 0001959173-26-002686-index.html | 0001959173-26-002686 |
| Document: 0001959173-26-002686.txt | 0001959173-26-002686 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 16, 2026 15w ago | Press Release | $20.49 $8.65 | ▼ −57.78% | ▼ −58.78% | $6.72 (−67.20%) |
May 8, 2026 21w ago | 8-K | $17.99 $11.20 | ▼ −37.74% | ▼ −42.58% | $6.72 (−62.65%) |
Apr 21, 2026 23w ago | DEFA14A | $18.36 $22.81 | ▲ +24.24% | ▲ +19.46% | $6.72 (−63.40%) |
Apr 21, 2026 23w ago | Press Release | $19.61 $22.16 | ▲ +13.00% | ▲ +6.10% | $6.72 (−65.73%) |
Apr 1, 2026 26w ago | 144 | $17.73 $24.95 | ▲ +40.72% | ▲ +27.34% | $6.72 (−62.10%) |
Mar 24, 2026 27w ago | Press Release | $16.11 $20.77 | ▲ +28.93% | ▲ +14.60% | $6.72 (−58.29%) |
Mar 2, 2026 30w ago | Court Ruling | $21.71 $16.95 | ▼ −21.93% | ▼ −31.26% | $6.72 (−69.05%) |
Feb 28, 2026 30w ago | Institutional Cluster | $21.71 $16.20 | ▼ −25.38% | ▼ −34.71% | $6.72 (−69.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access